National Cooperative Growth Study in CKD

Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.

NCT00184769 ·Status: COMPLETED ·Phase: PHASE4

Pharmacodynamics of CNP During Growth Hormone Treatment

NCT01504802 ·Status: COMPLETED

Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease

NCT00184652 ·Status: COMPLETED ·Phase: PHASE2

National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin

NCT00097539 ·Status: COMPLETED

Growth Hormone and Endothelial Function in Children

NCT00373386 ·Status: COMPLETED ·Phase: PHASE4

Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

NCT05382637 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects

NCT01343641 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation

NCT03535415 ·Status: UNKNOWN ·Phase: PHASE3

Observational Prospective Study on Patients Treated With Norditropin®

NCT00960128 ·Status: COMPLETED

Role of Nutrition and Hormones in Boys With Disordered Growth

NCT00102258 ·Status: COMPLETED ·Phase: PHASE2

304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency

NCT00362063 ·Status: UNKNOWN ·Phase: NA

Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children

NCT06103513 ·Status: RECRUITING ·Phase: PHASE3

Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency

NCT03288103 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children

NCT01604395 ·Status: RECRUITING

The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis

NCT00503698 ·Status: TERMINATED ·Phase: PHASE3

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

NCT02616562 ·Status: COMPLETED ·Phase: PHASE2

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

NCT00163189 ·Status: COMPLETED ·Phase: PHASE3

Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients

NCT00570011 ·Status: COMPLETED ·Phase: PHASE3

Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)

NCT00097526 ·Status: COMPLETED

Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

NCT03290235 ·Status: UNKNOWN ·Phase: PHASE4

A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency

NCT03305016 ·Status: COMPLETED ·Phase: PHASE3

Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

NCT00102817 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury

NCT00638053 ·Status: TERMINATED ·Phase: PHASE4

Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

NCT01947907 ·Status: COMPLETED ·Phase: PHASE2

Growth Hormone's Effect on the Cardiovascular System

NCT00397319 ·Status: TERMINATED